Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 19Thoracic 13Genitourinary 12Head & Neck 9Breast 9Other hematologic neoplasm 7Tumor-Agnostic 6Lymphoid 6Gynecologic 6Dermatologic 6CNS 5Endocrine 3Sarcoma 2Other solid neoplasm 2Myeloid 2Plasma cell 1Other 1Classical hematology 1

Conditions

Retinoblastoma 1Hematopoietic and Lymphoid System Neoplasm 1

Interventions

pembrolizumab 75Injections 67Carboplatin 38Pemetrexed 29Cisplatin 29Nivolumab 27Specimen Handling 24Interviews as Topic 24Cyclophosphamide 24atezolizumab 21tislelizumab 20Bevacizumab 20Paclitaxel 19Standard of Care 16Practice Guidelines as Topic 16fludarabine 15Docetaxel 15toripalimab 14Ipilimumab 14Educational Status 14Cetuximab 14Fluorouracil 13Oxaliplatin 12Etoposide 12olaparib 11durvalumab 11Methods 11Gemcitabine 11Early Intervention, Educational 11Drug Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observation × Other solid neoplasm × 1 year × Clear all
NCT05873608 2026-04-06

Communication Issues in Patient and Provider Discussions of Immunotherapy

Emory University

Phase NA Recruiting
125 enrolled
Other solid neoplasm

Hematopoietic and Lymphoid System Neoplasm

NCT02870907 2026-01-07

RB SFCE 09

Institut Curie

Phase 2 Active not recruiting
195 enrolled
Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡